Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of “Hold” from Analysts

Health Catalyst, Inc. (NASDAQ:HCAT) has been given a consensus rating of “Hold” by the thirteen brokerages that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $2.9318.

A number of research analysts have weighed in on the stock. Canaccord Genuity Group lifted their price objective on shares of Health Catalyst from $2.00 to $3.00 and gave the company a “buy” rating in a report on Tuesday, July 21st. Weiss Ratings upgraded Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 28th. Wells Fargo & Company cut their price target on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating for the company in a research note on Thursday. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Health Catalyst in a report on Monday, May 11th. Finally, Stephens reduced their price target on Health Catalyst from $2.00 to $1.75 and set an “equal weight” rating for the company in a report on Tuesday, May 12th.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. AQR Capital Management LLC grew its stake in Health Catalyst by 816.8% in the 1st quarter. AQR Capital Management LLC now owns 168,344 shares of the company’s stock valued at $763,000 after acquiring an additional 149,981 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Health Catalyst by 7.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,047 shares of the company’s stock worth $163,000 after acquiring an additional 2,624 shares during the period. Focus Partners Wealth acquired a new position in Health Catalyst during the first quarter worth $46,000. Geode Capital Management LLC lifted its holdings in Health Catalyst by 11.4% during the second quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock valued at $6,269,000 after purchasing an additional 169,580 shares in the last quarter. Finally, Rhumbline Advisers lifted its holdings in Health Catalyst by 13.5% during the second quarter. Rhumbline Advisers now owns 101,986 shares of the company’s stock valued at $384,000 after purchasing an additional 12,127 shares in the last quarter. 85.00% of the stock is owned by institutional investors and hedge funds.

Health Catalyst Stock Performance

Health Catalyst stock opened at $1.85 on Wednesday. The company has a current ratio of 2.70, a quick ratio of 2.70 and a debt-to-equity ratio of 1.51. Health Catalyst has a 12 month low of $0.96 and a 12 month high of $3.80. The stock’s 50 day simple moving average is $2.00 and its two-hundred day simple moving average is $1.69. The firm has a market cap of $139.23 million, a PE ratio of -0.50 and a beta of 1.55.

Health Catalyst (NASDAQ:HCAT) last posted its earnings results on Thursday, August 6th. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.01. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. The firm had revenue of $70.49 million during the quarter, compared to analyst estimates of $69.09 million. Analysts anticipate that Health Catalyst will post -0.25 earnings per share for the current year.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.